Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients
Clinical trial NCT02927366 · TERMINATED
Trial details
- NCT number
- NCT02927366
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2018-06-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.